The aim of this study was to find out whether intermittent preventive treatment ( IPT ) with a fixed-dose combination of mefloquine-artesunate ( MQAS ) or sulfadoxine-pyrimethamine plus amodiaquine ( SPAQ ) was more effective than daily proguanil for malaria prevention in subjects with SCD .